Literature DB >> 20013304

Predictive performance for population models using stochastic differential equations applied on data from an oral glucose tolerance test.

Jonas B Møller1, Rune V Overgaard, Henrik Madsen, Torben Hansen, Oluf Pedersen, Steen H Ingwersen.   

Abstract

Several articles have investigated stochastic differential equations (SDEs) in PK/PD models, but few have quantitatively investigated the benefits to predictive performance of models based on real data. Estimation of first phase insulin secretion which reflects beta-cell function using models of the OGTT is a difficult problem in need of further investigation. The present work aimed at investigating the power of SDEs to predict the first phase insulin secretion (AIR (0-8)) in the IVGTT based on parameters obtained from the minimal model of the OGTT, published by Breda et al. (Diabetes 50(1):150-158, 2001). In total 174 subjects underwent both an OGTT and a tolbutamide modified IVGTT. Estimation of parameters in the oral minimal model (OMM) was performed using the FOCE-method in NONMEM VI on insulin and C-peptide measurements. The suggested SDE models were based on a continuous AR(1) process, i.e. the Ornstein-Uhlenbeck process, and the extended Kalman filter was implemented in order to estimate the parameters of the models. Inclusion of the Ornstein-Uhlenbeck (OU) process caused improved description of the variation in the data as measured by the autocorrelation function (ACF) of one-step prediction errors. A main result was that application of SDE models improved the correlation between the individual first phase indexes obtained from OGTT and AIR (0-8) (r = 0.36 to r = 0.49 and r = 0.32 to r = 0.47 with C-peptide and insulin measurements, respectively). In addition to the increased correlation also the properties of the indexes obtained using the SDE models more correctly assessed the properties of the first phase indexes obtained from the IVGTT. In general it is concluded that the presented SDE approach not only caused autocorrelation of errors to decrease but also improved estimation of clinical measures obtained from the glucose tolerance tests. Since, the estimation time of extended models was not heavily increased compared to basic models, the applied method is concluded to have high relevance not only in theory but also in practice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20013304     DOI: 10.1007/s10928-009-9145-5

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  28 in total

1.  Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity.

Authors:  E Breda; M K Cavaghan; G Toffolo; K S Polonsky; C Cobelli
Journal:  Diabetes       Date:  2001-01       Impact factor: 9.461

2.  Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects.

Authors:  Andrea Mari; Ole Schmitz; Amalia Gastaldelli; Torben Oestergaard; Birgit Nyholm; Ele Ferrannini
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-08-06       Impact factor: 4.310

3.  A population-based Bayesian approach to the minimal model of glucose and insulin homeostasis.

Authors:  Kim E Andersen; Malene Højbjerre
Journal:  Stat Med       Date:  2005-08-15       Impact factor: 2.373

4.  The BIGTT test: a novel test for simultaneous measurement of pancreatic beta-cell function, insulin sensitivity, and glucose tolerance.

Authors:  Torben Hansen; Thomas Drivsholm; Søren A Urhammer; Rene T Palacios; Aage Vølund; Knut Borch-Johnsen; Oluf Pedersen
Journal:  Diabetes Care       Date:  2007-02       Impact factor: 19.112

5.  The impact of misspecification of residual error or correlation structure on the type I error rate for covariate inclusion.

Authors:  Hanna E Silber; Maria C Kjellsson; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-02-14       Impact factor: 2.745

6.  Insulin release in impaired glucose tolerance: oral minimal model predicts normal sensitivity to glucose but defective response times.

Authors:  Elena Breda; Gianna Toffolo; Kenneth S Polonsky; Claudio Cobelli
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

7.  Modeling the euglycemic hyperinsulinemic clamp by stochastic differential equations.

Authors:  Umberto Picchini; Susanne Ditlevsen; Andrea De Gaetano
Journal:  J Math Biol       Date:  2006-10-05       Impact factor: 2.259

8.  Pancreatic beta-cell responsiveness during meal tolerance test: model assessment in normal subjects and subjects with newly diagnosed noninsulin-dependent diabetes mellitus.

Authors:  R Hovorka; L Chassin; S D Luzio; R Playle; D R Owens
Journal:  J Clin Endocrinol Metab       Date:  1998-03       Impact factor: 5.958

9.  Stochastic differential equations in NONMEM: implementation, application, and comparison with ordinary differential equations.

Authors:  Christoffer W Tornøe; Rune V Overgaard; Henrik Agersø; Henrik A Nielsen; Henrik Madsen; E Niclas Jonsson
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

10.  A mathematical model of the oral glucose tolerance test illustrating the effects of the incretins.

Authors:  Patricia L Brubaker; Elan L Ohayon; Lisa M D'Alessandro; Kenneth H Norwich
Journal:  Ann Biomed Eng       Date:  2007-03-29       Impact factor: 3.934

View more
  6 in total

1.  Mechanism-based population modelling for assessment of L-cell function based on total GLP-1 response following an oral glucose tolerance test.

Authors:  Jonas B Møller; William J Jusko; Wei Gao; Torben Hansen; Oluf Pedersen; Jens J Holst; Rune V Overgaard; Henrik Madsen; Steen H Ingwersen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-09-16       Impact factor: 2.745

2.  Predicting Plasma Glucose From Interstitial Glucose Observations Using Bayesian Methods.

Authors:  Alexander Hildenbrand Hansen; Anne Katrine Duun-Henriksen; Rune Juhl; Signe Schmidt; Kirsten Nørgaard; John Bagterp Jørgensen; Henrik Madsen
Journal:  J Diabetes Sci Technol       Date:  2014-03-06

3.  Model identification using stochastic differential equation grey-box models in diabetes.

Authors:  Anne Katrine Duun-Henriksen; Signe Schmidt; Rikke Meldgaard Røge; Jonas Bech Møller; Kirsten Nørgaard; John Bagterp Jørgensen; Henrik Madsen
Journal:  J Diabetes Sci Technol       Date:  2013-03-01

4.  Using sensitivity equations for computing gradients of the FOCE and FOCEI approximations to the population likelihood.

Authors:  Joachim Almquist; Jacob Leander; Mats Jirstrand
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-03-24       Impact factor: 2.745

5.  Modeling Variability in the Progression of Huntington's Disease A Novel Modeling Approach Applied to Structural Imaging Markers from TRACK-HD.

Authors:  J H Warner; C Sampaio
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-08-02

6.  Evolving data analysis of an Oral Lipid Tolerance Test toward the standard for the Oral Glucose Tolerance Test: Cross species modeling effects of AZD7687 on plasma triacylglycerol.

Authors:  Pablo Morentin Gutierrez; James Yates; Catarina Nilsson; Sue Birtles
Journal:  Pharmacol Res Perspect       Date:  2019-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.